Danxia

About:

Danxia develops biological blood products.

Website: http://www.danxia-biopharm.com/

Top Investors: GF Xinde Investment Management, ShenZhen GTJA Investment Group, Soochow Venture Capital, Ch-gemstone capital, Orient Minerva Asset

Description:

Danxia has the capacity to produce integrated machines. They offer forms of assistance to domestic producers while offering their clients premium products, technical assistance services.

Total Funding Amount:

13M CNY

Headquarters Location:

Guangzhou Shi, Guangdong, China

Founded Date:

2002-04-19

Founders:

Number of Employees:

101-250

Last Funding Date:

2016-12-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai